Gb Sciences Stock Buy Hold or Sell Recommendation
| GBLX Stock | USD 0.01 0 84.37% |
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding GB Sciences is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell GB Sciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for GB Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out GB Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as GBLX and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards GB Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
GBLX |
Execute GB Sciences Buy or Sell Advice
The GBLX recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on GB Sciences. Macroaxis does not own or have any residual interests in GB Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute GB Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
GB Sciences Trading Alerts and Improvement Suggestions
| GB Sciences is way too risky over 90 days horizon | |
| GB Sciences has some characteristics of a very speculative penny stock | |
| GB Sciences appears to be risky and price may revert if volatility continues | |
| GB Sciences has high likelihood to experience some financial distress in the next 2 years | |
| GB Sciences currently holds 397.31 K in liabilities with Debt to Equity (D/E) ratio of 1.07, which is about average as compared to similar companies. GB Sciences has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist GB Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, GB Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like GB Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for GBLX to invest in growth at high rates of return. When we think about GB Sciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (530.87 K) with loss before overhead, payroll, taxes, and interest of (881.46 K). | |
| GB Sciences currently holds about 53.96 K in cash with (1.87 M) of positive cash flow from operations. | |
| Roughly 13.0% of GB Sciences shares are held by company insiders |
GB Sciences Returns Distribution Density
The distribution of GB Sciences' historical returns is an attempt to chart the uncertainty of GB Sciences' future price movements. The chart of the probability distribution of GB Sciences daily returns describes the distribution of returns around its average expected value. We use GB Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of GB Sciences returns is essential to provide solid investment advice for GB Sciences.
| Mean Return | 80.17 | Value At Risk | -50 | Potential Upside | 100.00 | Standard Deviation | 50.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of GB Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
GB Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to GB Sciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that GB Sciences' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a GBLX pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 86.83 | |
β | Beta against Dow Jones | -65.52 | |
σ | Overall volatility | 184.83 | |
Ir | Information ratio | 0.13 |
GB Sciences Volatility Alert
GB Sciences is showing large volatility of returns over the selected time horizon. GB Sciences is a penny stock. Even though GB Sciences may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in GB Sciences or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on GBLX instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.GB Sciences Fundamentals Vs Peers
Comparing GB Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze GB Sciences' direct or indirect competition across all of the common fundamentals between GB Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as GB Sciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of GB Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing GB Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare GB Sciences to competition |
| Fundamentals | GB Sciences | Peer Average |
| Return On Equity | -50.98 | -0.31 |
| Return On Asset | -0.21 | -0.14 |
| Current Valuation | 10.19 M | 16.62 B |
| Shares Outstanding | 379.21 M | 571.82 M |
| Shares Owned By Insiders | 13.08 % | 10.09 % |
| Price To Earning | 4.04 X | 28.72 X |
| Price To Book | 1.08 X | 9.51 X |
| Price To Sales | 1.91 X | 11.42 X |
| Gross Profit | (881.46 K) | 27.38 B |
| EBITDA | 398.73 K | 3.9 B |
| Net Income | (530.87 K) | 570.98 M |
| Cash And Equivalents | 53.96 K | 2.7 B |
| Total Debt | 397.31 K | 5.32 B |
| Debt To Equity | 1.07 % | 48.70 % |
| Current Ratio | 0.03 X | 2.16 X |
| Book Value Per Share | (0) X | 1.93 K |
| Cash Flow From Operations | (1.87 M) | 971.22 M |
| Number Of Employees | 3 | 18.84 K |
| Beta | 0.56 | -0.15 |
| Market Capitalization | 8.21 M | 19.03 B |
| Total Asset | 2.55 M | 29.47 B |
| Retained Earnings | (78.28 M) | 9.33 B |
| Working Capital | 881 K | 1.48 B |
| Current Asset | 2.2 M | 9.34 B |
| Current Liabilities | 1.32 M | 7.9 B |
| Z Score | -30.0 | 8.72 |
| Net Asset | 2.55 M |
GB Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as GBLX . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About GB Sciences Buy or Sell Advice
When is the right time to buy or sell GB Sciences? Buying financial instruments such as GBLX Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having GB Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Growth Thematic Idea Now
Tech Growth
Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. The Tech Growth theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for GBLX Pink Sheet Analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.